Su‐Kang Shan
- Cancer Research top 5%
- MicroRNA in disease regulation 13
- Nephrology top 10%
-
- Extracellular vesicles in disease 16
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 4
- Circular RNAs in diseases 4
-
- Cardiovascular Disease and Adiposity 5
-
- Adipose Tissue and Metabolism 5
-
- Adipokines, Inflammation, and Metabolic Diseases 3
- Journals
- SHILAP Revista de lepidopterología (1 paper)Journal of Bone and Mineral Research (1 paper)Obesity Reviews (1 paper)
- Partner nations
- China
In The Last Decade
Su‐Kang Shan
32 papers receiving 992 citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 337
- Nephrology 85
- Molecular Biology 636
- Genetics 63
- Aging 10
Countries citing papers authored by Su‐Kang Shan
This map shows the geographic impact of Su‐Kang Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Kang Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Kang Shan more than expected).
Fields of papers citing papers by Su‐Kang Shan
This network shows the impact of papers produced by Su‐Kang Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Kang Shan. The network helps show where Su‐Kang Shan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Su‐Kang Shan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical studybreakdown → | 2023 | 222 |
| 7 | 2023 | 4 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 47 | |
| 13 | 2022 | 21 | |
| 14 | 2021 | 31 | |
| 15 | 2021 | 33 | |
| 16 | 2021 | 54 | |
| 17 | 2021 | 18 | |
| 18 | 2020 | 27 | |
| 19 | 2020 | 20 | |
| 20 | 2020 | 48 |
About Su‐Kang Shan
Su‐Kang Shan is a scholar working on Cancer Research, Molecular Biology and Nephrology, having authored 34 papers that have together received 1.0k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (16 papers), MicroRNA in disease regulation (13 papers), Cardiovascular Disease and Adiposity (5 papers), Adipose Tissue and Metabolism (5 papers), Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Cancer Research (337 citations), Nephrology (85 citations) and Molecular Biology (636 citations). Su‐Kang Shan has collaborated with scholars based in China. Frequent co-authors include Ling‐Qing Yuan, Fu‐Xing‐Zi Li, Bei Guo, Xiao Lin, Feng Xu, Ming-Hui Zheng, Feng Wu, Jia‐Yu Zhong, Xiao‐Bo Liao and Changchun Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Bone and Mineral Research and Obesity Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.